Sucralfate and basic fibroblast growth factor promote endothelial cell proliferation around porous alloplastic implants in vitro

Ophthalmic Plastic and Reconstructive Surgery

Volumn 12, Issue 4, 1996, Pages 235-239

  Nicaeus, Thilo E ^a   Tolentino, Michael J ^a   Adamis, Anthony P ^a   Rubin, Peter A D ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

basic fibroblast growth factor; Hydron; Hydroxyapatite; Porous polyethylene; Proliferation; Sucralfate

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HYDROXYAPATITE; POLYETHYLENE; POLYMACON; POLYMER; SUCRALFATE;

ALLOGRAFT; ANIMAL CELL; ARTICLE; CAPILLARY ENDOTHELIUM; CATTLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; NONHUMAN; ORBIT IMPLANT; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

EID: 0029826303     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002341-199612000-00004     Document Type: Article

References (17)

1. Rubin PAD, Popham J, Shore JW. Comparison of fibrovascular ingrowth into hydroxyapatite and porous polyethylene orbital implants. Ophthalmic Plast Reconstr Surg 1994;10:96-103.
2. Ausprunk DH, Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 1977;14:53.
3. Klagsbrun M, Vlodavsky I. Biosynthesis and storage of bFGF by endothelial cells. Implications for the mechanisms of action of angiogenesis. In: Barbul A, Piens E, Caldwell, et al. eds Growth factors and other aspects of wound healing. Biological and clinical implications. New York: Alan R. Liss, 1988:55.
4. Montesano R, Vassalli JD, Baird A, et al. BFGF induces angiogenesis in vitro. Proc Natl Acad Sci USA 1986;83:7297-301.
5. Folkman J, Klagsburn M, Sasse J, et al. A heparin-binding angiogenic protein - bFGF - is stored within basement membrane. Am J Pathol 1988;130:393-400.
6. Dano K, Andreasen PA, Grondahl-Hansen J, et al. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985;44.146-239.
7. Moscatelli D, Rifkin DB. Membrane and matrix localization of proteases: a common theme in tumor invasion and angiogenesis. Biochim Biophys Acta 1988;948:67-85.
8. Mullins DE, Rohrlich ST. The role of proteinases in cellular invasiveness. Biochim Biophys Acta 1983;695:177-214.
9. Folkman J, Szabo S, Stovroff M, et al. Duodenal Ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg 1991;214:414-25.
10. Gospodarowicz D, Bialecki H, Thakral TK The angiogenic activity of the fibroblast and epidermal growth factor. Exp Eye Res 1979;28:501-14.
11. Folkman J, Haudenschild CC, Zetter BR. Long-term culture of capillary endothelial cells. Proc Natl Acad Sci USA 1979;76:5217.
12. Smith S, D'Amore PA, Dreyer EB. Comparative toxicity of mitomycin C and 5-fluorouracil in vitro. Am J Ophthalmol 1994;118:332-7.
13. 3H]-thymidine uptake in retinal venular and capillary endothelial cells in vivo. Invest Ophthalmol Vis Sci 1990;31:1238-43.
14. Szabo S. The mode of action of sucralfate: the 1×1×1 mechanism of action. Scand J Gastroenterol 1992; 185 (suppl):7-12.
15. Gibran NS, Isik FF, Heimbach DM, et al. Basic fibroblast growth factor in the early human burn wound. J Surg Res 1994;56:226-34.
16. Villaschi S, Nicosia RF. Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. Am J Pathol 1993;143:181-90.
17. Slavin J, Hunt JA, Nash JR, et al. Recombinant basic fibroblast growth factor in red blood cell ghosts accelerates incisional wound healing. Br J Surg 1992;79:918-20.